Marc Boisvert, MD, MBA, is director, Center for Breast Health, MedStar Washington Hospital Center (MWHC), and a clinical associate professor at MedStar Georgetown University Hospital. In addition, he is program director for the Fellowship in Breast Disease curriculum and surgical director for the Melanoma Center, both at MWHC.
Dr. Boisvert has participated in many clinical trials and has published his research in peer-reviewed journals, including Clinical Cancer Research, Journal of Immunotherapyand the Journal of Biomedical Optics. At MWHC, he serves as chairman of the Board of Directors for the Physician Hospital Organization.
Dr. Boisvert is a fellow of the Society of Surgical Oncology, where he serves on the Committee on Breast Fellowships. He is a fellow of the American College of Surgery and the Southeastern Surgical Society and is a member of the American Society of Breast Disease, the American Society of Breast Surgeons, the American Society of Clinical Oncology, the Washington Academy of Surgery and the American College of Surgeons. He is board certified in Surgery and was listed as a Top Doctor for Breast Cancer Surgery in the February 2012 issue of Washingtonian magazine.
He received his medical degree from Georgetown University, Washington, DC, and an MBA in Medical Services Management from the Carey Business School, Johns Hopkins University, in Baltimore. He completed an internship and residencies in Surgery and Medicine at the Hospital of St. Raphael, an affiliate of Yale University School of Medicine in New Haven, CT.
Dr. Marc Boisvert's research interests include
- Breast health
- Breast surgery
- Diagnosis and treatment of breast disease
- Breast cancer risk assessment and risk reduction
- Breast cancer surgery
- Breast-conserving surgery for breast cancer
- Areola and nipple-sparing mastectomy
- Ductal carcinoma in situ
- Sentinel node biopsy
- Locally advanced breast cancer
Pathologic Response to Neoadjuvant Chemotherapy in African-American Women with Breast Cancer
Dr. Boisvert and colleagues examined outcomes of neoadjuvant chemotherapy in African-American women compared with women of other ethnic groups. The results of this single-institution, retrospective study were presented as a poster presentation at a meeting of the American Society of Breast Disease.
African-Americans with Triple-Negative Breast Cancer
In another single-institution, retrospective trial, Dr. Bosivert and colleagues are studying outcomes in African-American patients with triple-negative breast cancer.
Improved Early Skin Cancer Diagnosis
Optimal treatment of skin cancer depends on early diagnosis and treatment, and valuable information can be obtained from analysis of skin texture. In this article, published in the Journal of Biomedical Optics(2012;17:076014), Dr. Boisvert and colleagues developed an out-of-plane hemispherical Stokes imaging polarimeter designed to monitor potential skin neoplasia based on an assessment of skin roughness.
Melanoma Vaccine Reformulated to Avoid Risk of Mad Cow Disease
An experimental cancer vaccine has been reformulated, with the use of beef tallow replaced by a vegetarian component, because of concerns about risk of mad cow disease. In this article, published in the Journal of Immunotherapy (2010;33:630-638), Dr. Boisvert and colleagues determined that their data support use of the new formulation in melanoma patients.
- Research Areas